Jefferies Downgrades USANA Health Sciences (USNA) to Underperform
More News related to USNA
- USANA Health Sciences Launches Vitamin D Supplement
- USANA Supported Clinical Study Demonstrates Improved Bone Health in Girls
- Analyst Defends USANA (USNA) as Shares Plunge: Upgrades to Buy
- Morning Movers 10/28: CSBC, QTM, ANIK, RSYS, PEET, WSII Higher; CALC, KSP, PSYS, VCLK, VPHM, GT Lower
- USANA Health Sciences (USNA) Posts Q3 EPS of $0.51, Beats By 3c; Guides FY09
More News related to Downgrades
- RBC Capital Downgrades Church & Dwight (CHD) from Top Pick to Outperform
- JMP Securities Downgrades NuVasive (NUVA) to Market Perform
- Brean Murray Downgrades NuVasive (NUVA) to Hold; Reimbursement Issues Struck a Nerve
- Merriman Curhan Ford Downgrades Netflix (NFLX) to Neutral; Risk Lies More With Initial 1Q Guidance
Jefferies downgrades USANA Health Sciences (Nasdaq: USNA) from Hold to Underperform with a $32 price target.
Shares of USANA Health are down 1.7% to $37.51 today.
USANA Health Sciences, Inc. develops, manufactures, and distributes nutritional and personal care products.
Related Categories
DowngradesStocks Mentioned
+0.52Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
